Armis Centrix™ Medical Device Security vs Asimily Vulnerability Prioritization: Side-by-Side Comparison (2026)

Short answer

Mid-market and enterprise healthcare security teams need medical device visibility that doesn't break clinical workflows, and Armis Centrix™ delivers this through agentless discovery and a Clinical Impact Score that prioritizes threats by patient safety risk rather than generic severity. The platform covers the full ID.AM to DE.AE arc (asset discovery through anomaly analysis) and handles the legacy device inventory that most hospitals refuse to upgrade, which is where 80 percent of the actual risk lives. Skip this if your organization runs primarily modern, patchable infrastructure; Centrix is purpose-built for the messy reality of connected anesthesia machines and decades-old imaging systems, not general IT asset management. Mid-market and enterprise security teams managing sprawling IoT, OT, and medical device networks should use Asimily Vulnerability Prioritization to stop drowning in false-positive patch queues; its device-level risk simulation and network-configuration-aware scoring actually separate critical threats from noise instead of just ranking CVEs by CVSS. The platform covers all four NIST CSF 2.0 asset management and risk assessment functions, with automatic inventory discovery that IT teams consistently lack visibility into. Skip this if your environment is purely IT-centric servers and endpoints; Asimily's value erodes when you don't have legacy or specialized hardware creating the prioritization headache it solves.